Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Share-based Compensation (2016 - 2022)

Historic Share-based Compensation for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to -$740000.0.

  • MediWound's Share-based Compensation rose 2925.43% to -$740000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 45617.53%. This contributed to the annual value of -$3.1 million for FY2024, which is 26175.26% down from last year.
  • According to the latest figures from Q3 2025, MediWound's Share-based Compensation is -$740000.0, which was up 2925.43% from $862000.0 recorded in Q2 2025.
  • MediWound's Share-based Compensation's 5-year high stood at $862000.0 during Q2 2025, with a 5-year trough of -$1.0 million in Q3 2024.
  • Its 5-year average for Share-based Compensation is $138052.6, with a median of $345000.0 in 2022.
  • Its Share-based Compensation has fluctuated over the past 5 years, first plummeted by 27942.03% in 2023, then soared by 26484.38% in 2025.
  • Quarter analysis of 5 years shows MediWound's Share-based Compensation stood at -$390000.0 in 2021, then crashed by 64.62% to -$642000.0 in 2022, then surged by 146.42% to $298000.0 in 2023, then soared by 175.84% to $822000.0 in 2024, then tumbled by 190.02% to -$740000.0 in 2025.
  • Its Share-based Compensation stands at -$740000.0 for Q3 2025, versus $862000.0 for Q2 2025 and $844000.0 for Q1 2025.